MRI has emerged as the most comprehensive noninvasive diagnostic tool for focal liver
lesions and diffuse hepatobiliary disorders. The introduction of hepatobiliary contrast agents …

Portal hypertension (PH) is a spectrum of complications of chronic liver disease (CLD) and
cirrhosis, with manifestations including ascites, gastroesophageal varices, splenomegaly …

Purpose To determine whether hepatocyte uptake ratios derived at gadoxetic acid–
enhanced MRI correlate with quantitative measures of liver function and can help to identify …

Objectives To compare the value of functional future liver remnant (functFLR) to established
clinical and imaging variables in prediction of post-hepatectomy liver failure (PHLF) after …

Purpose To determine whether B1 inhomogeneity–corrected volumetric T1 maps of
gadoxetic acid–enhanced liver magnetic resonance (MR) imaging are able to demonstrate …

Purpose This study aimed to (i) develop Magnetization‐Prepared Golden‐angle RAdial
Sparse Parallel (MP‐GRASP) MRI using a stack‐of‐stars trajectory for rapid free‐breathing …

Objectives To compare look-locker inversion recovery (LLIR) and B 1 inhomogeneity–
corrected variable flip angle T1 mapping methods for estimation of liver function and …

Fibrotic diseases affect multiple organs and are associated with morbidity and mortality. To
examine organ-specific and shared biologic mechanisms that underlie fibrosis in different …

AIM To assess the accuracy of Look-Locker on gadolinium ethoxybenzyl diethylenetriamine
pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) for staging …

Purpose To describe and validate a simultaneous proton density fat‐fraction (PDFF) imaging
and water‐specific T1 mapping (T1 (Water)) approach for the liver (PROFIT1) with mapping …